{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:10:08Z","timestamp":1790197808576,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K08529"],"award-info":[{"award-number":["21K08529"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015758","name":"Novo Nordisk Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clnesp.2023.12.005","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T20:25:23Z","timestamp":1701894323000},"page":"208-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetes"],"prefix":"10.1016","volume":"59","author":[{"given":"Tsukasa","family":"Kuriyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4170-3661","authenticated-orcid":false,"given":"Chisaki","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9665-8947","authenticated-orcid":false,"given":"Junji","family":"Kozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megu Y.","family":"Baden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Niki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-6745","authenticated-orcid":false,"given":"Harutoshi","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5505-1724","authenticated-orcid":false,"given":"Yoshiya","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-5654","authenticated-orcid":false,"given":"Yukari","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Sadahiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2023.12.005_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12997","article-title":"Adipokine dysregulation and adipose tissue inflammation in human obesity","volume":"48","author":"Unamuno","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clnesp.2023.12.005_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00134-019-05594-1","article-title":"Obesity in the critically ill: a narrative review","volume":"45","author":"Schetz","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clnesp.2023.12.005_bib3","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/ATVBAHA.114.303035","article-title":"Links between ectopic fat and vascular disease in humans","volume":"34","author":"Lim","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnesp.2023.12.005_bib5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/oby.2007.110","article-title":"Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition","volume":"16","author":"Pinnick","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.clnesp.2023.12.005_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrgastro.2011.4","article-title":"The clinical significance of pancreatic steatosis","volume":"8","author":"Smits","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41574-021-00573-3","article-title":"Metabolic implications of pancreatic fat accumulation","volume":"18","author":"Wagner","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/jdi.13108","article-title":"Pancreatic fat is related to the longitudinal decrease in the increment of C-peptide in glucagon stimulation test in type 2 diabetes patients","volume":"11","author":"Ishibashi","year":"2020","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.clnesp.2023.12.005_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1507\/endocrj.EJ18-0436","article-title":"Pancreatic fat content is associated with \u03b2-cell function and insulin resistance in Chinese type 2 diabetes subjects","volume":"66","author":"Lu","year":"2019","journal-title":"Endocr J"},{"key":"10.1016\/j.clnesp.2023.12.005_bib10","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/MPA.0000000000001109","article-title":"Glucose intolerance after pancreatectomy was associated with preoperative hemoglobin A1c, insulin resistance, and histological pancreatic fatty infiltration","volume":"47","author":"Ishibashi","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.clnesp.2023.12.005_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721135","article-title":"GLP-1 receptor agonists: beyond their pancreatic effects","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1475-2840-11-107","article-title":"Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes","volume":"11","author":"Fujishima","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib13","first-page":"407","article-title":"Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes: the Lira-NAFLD study","volume":"102","author":"Petit","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2023.12.005_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clnesp.2023.12.005_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2468-1253(21)00261-2","article-title":"Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review","volume":"7","author":"Mantovani","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib16","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1007\/s00125-020-05265-7","article-title":"Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)","volume":"63","author":"Kuchay","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2023.12.005_bib17","doi-asserted-by":"crossref","first-page":"14821","DOI":"10.3748\/wjg.v20.i40.14821","article-title":"Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation","volume":"20","author":"Wang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A\u00a0placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnesp.2023.12.005_bib19","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.2337\/dc21-2049","article-title":"Comparison of tofogliflozin and glimepiride effects on nonalcoholic fatty liver disease in participants with type 2 diabetes: a randomized, 48-week, open-Label, active-controlled trial","volume":"45","author":"Takeshita","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnesp.2023.12.005_bib20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/dom.12680","article-title":"Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy","volume":"18","author":"Dutour","year":"2016","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib21","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1210\/jc.2015-3906","article-title":"Mechanisms of action of liraglutide in patients with type 2 diabetes treated with high-dose insulin","volume":"101","author":"Vanderheiden","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2023.12.005_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.819606","article-title":"Pancreas fat, an early marker of metabolic risk? A magnetic resonance study of Chinese and caucasian women: TOFI_Asia study","volume":"13","author":"Sequeira","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib23","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1111\/dom.13447","article-title":"Comparison of pancreatic volume and fat amount linked with glucose homeostasis between healthy Caucasians and Koreans","volume":"20","author":"Roh","year":"2018","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/osp4.482","article-title":"Amelioration of pancreatic fat accumulation in Japanese type 2 diabetes patients treated with sodium-glucose cotransporter 2 inhibitors: a retrospective study","volume":"7","author":"Horii","year":"2021","journal-title":"Obes Sci Pract"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2023.12.005_bib25","first-page":"S125","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.clnesp.2023.12.005_bib26","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1128\/MCB.19.5.3760","article-title":"ADD1\/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose","volume":"19","author":"Foretz","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"19","key":"10.1016\/j.clnesp.2023.12.005_bib27","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1073\/pnas.0401516101","article-title":"Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis","volume":"101","author":"Iizuka","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clnesp.2023.12.005_bib28","doi-asserted-by":"crossref","first-page":"104-12","DOI":"10.1148\/radiol.13122883","article-title":"Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications","volume":"271","author":"Kim","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.clnesp.2023.12.005_bib29","doi-asserted-by":"crossref","first-page":"105-12","DOI":"10.1148\/radiol.2391050361","article-title":"Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment","volume":"239","author":"Park","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.clnesp.2023.12.005_bib30","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3748\/wjg.15.1869","article-title":"Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome","volume":"15","author":"Lee","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.47717\/turkjsurg.2020.4877","article-title":"The relation of CT quantified pancreatic fat index with visceral adiposity and hepatic steatosis","volume":"36","author":"Gursoy Coruh","year":"2020","journal-title":"Turk J Surg"},{"key":"10.1016\/j.clnesp.2023.12.005_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.34172\/mejdd.2021.245","article-title":"Determinants of pancreatic steatosis: a retrospective observational study","volume":"13","author":"Altinmakas","year":"2021","journal-title":"Middle East J Dig Dis"},{"key":"10.1016\/j.clnesp.2023.12.005_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/dom.12012","article-title":"Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study","volume":"15","author":"Nauck","year":"2013","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib34","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ijo.2011.158","article-title":"Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide","volume":"36","author":"Astrup","year":"2012","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnesp.2023.12.005_bib35","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2014.12.021","article-title":"Effect of liraglutide on proliferation and differentiation of human adipose stem cells","volume":"402","author":"Cantini","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib37","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1074\/jbc.M111.310342","article-title":"Regulation of adipocyte formation by GLP-1\/GLP-1R signaling","volume":"287","author":"Challa","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clnesp.2023.12.005_bib38","first-page":"221","article-title":"Adipose triglyceride lipase regulation: an overview","volume":"19","author":"Cerk","year":"2018","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.clnesp.2023.12.005_bib39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/db19-0951","article-title":"Adipose triglyceride lipase is a key lipase for the mobilization of lipid droplets in human \u03b2-cells and critical for the maintenance of syntaxin 1a levels in \u03b2-cells","volume":"69","author":"Liu","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.clnesp.2023.12.005_bib40","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00125-016-3896-5","article-title":"GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1","volume":"59","author":"Xu","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2023.12.005_bib41","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/diabetes.52.7.1591","article-title":"Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival?","volume":"52","author":"Markmann","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.clnesp.2023.12.005_bib42","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2337\/diabetes.53.5.1311","article-title":"Prevalence of hepatic steatosis after islet transplantation and its relation to graft function","volume":"53","author":"Bhargava","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.clnesp.2023.12.005_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2214\/ajr.176.2.1760471","article-title":"Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging","volume":"176","author":"Sohn","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clnesp.2023.12.005_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1440-1827.2007.02190.x","article-title":"Focal hepatic steatosis surrounding a metastatic insulinoma","volume":"58","author":"Takeshita","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.clnesp.2023.12.005_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-021-00551-0","article-title":"Intra-pancreatic fat deposition: bringing hidden fat to the fore","volume":"19","author":"Petrov","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723022301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723022301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:10:14Z","timestamp":1762499414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457723022301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":45,"alternative-id":["S2405457723022301"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.12.005","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}